<DOC>
	<DOCNO>NCT01272973</DOCNO>
	<brief_summary>This trial conduct Europe . The aim trial investigate safety , tolerability , pharmacokinetics ( rate body eliminate trial drug ) pharmacodynamics ( effect investigate drug body ) NN9924 healthy male subject</brief_summary>
	<brief_title>Investigation Safety , Tolerability , Pharmacokinetics Pharmacodynamics NN9924 Healthy Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Healthy male subject , base assessment medical history , physical examination BMI 21 30 kg/m2 ( 21 inclusive ) Male subject sexually active unwilling use highly effective method contraception nonpregnant partner Any clinically significant , abnormal disease history follow system : cardiopulmonary , gastrointestinal , hepatic , neurological , renal , genitourinary , endocrine haematological The receipt investigational product within 90 day screen , currently enrol clinical trial</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>